Research On Tumor Necrosis Factor Growing Explosively

Tumor necrosis factor (TNF) has been over the past few years one of the more actively investigated proteins among those involved in inflammation, immunity, and the growth and inhibition of cells. TNF is destructive to cancer— hence, its name. Loyd J. Old and colleagues at the Memorial Sloan-Kettering Cancer Center in New York discovered TNF some 15 years ago. But it was only in 1984 that research into TNF really began to take off. “The decade-long effort to purify tumor necrosis

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Tumor necrosis factor (TNF) has been over the past few years one of the more actively investigated proteins among those involved in inflammation, immunity, and the growth and inhibition of cells. TNF is destructive to cancer— hence, its name.

Loyd J. Old and colleagues at the Memorial Sloan-Kettering Cancer Center in New York discovered TNF some 15 years ago. But it was only in 1984 that research into TNF really began to take off. “The decade-long effort to purify tumor necrosis factor finally culminated in 1984 with the cloning of the gene, the identification of the protein’s amino acid sequence and the production of large quantities of the factor,” Old wrote recently. “Since then there has been an explosion of information about the factor’s activities” (Scientific American, 258 (5), 70, May 1988). A 1987 research front—a cluster of 1987 papers and the earlier publications they consistently cite—on TNF (ISI #0307) ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies